Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00468338
Other study ID # 0120060266
Secondary ID
Status Completed
Phase N/A
First received April 30, 2007
Last updated October 28, 2016
Start date December 2006
Est. completion date May 2008

Study information

Verified date April 2015
Source Rutgers, The State University of New Jersey
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The BIS monitor is a tool which assists anesthesiologists in monitoring the depth of anesthesia or level of anesthesia. The study doctors would like to see if it is useful tool for patients who are mentally challenged and require anesthesia.


Description:

General endotracheal tube anesthesia (GETA) is administered for mentally retarded patients that need dental rehabilitation. GETA is done, in all patients, with routine monitoring of electrocardiography, blood pressure recording, pulse oximetry and end-tidal capnography. These measurements are also used indirectly to determine the depth of anesthesia and the anesthetic is titrated to prevent awareness during surgery and any subsequent recall (1). In addition, a recently introduced functional electroencephalography (EEG)-based awareness monitor directly analyzes the brain wave pattern during anesthetic delivery and aids the anesthesiologist in maintaining the ideal depth of anesthesia. The EEG based monitor serves to prevent awareness and recall due to light anesthesia or prolonged recovery following deep anesthesia (2). This instrument, named the Bispectral Index Scale (BIS) monitor, is non-invasive and is approved by the Food & Drug Administration. However, the BIS monitor is not being used routinely during the anesthetic management of mentally retarded patients due to a belief that such monitoring would be inaccurate in this cohort of patients (3). This assumption lacks scientific validation. Our trial will investigate the usefulness of BIS monitoring in mentally retarded patients and document any correlation between the severity of mental retardation and BIS scoring during various phases of anesthesia, such as awake status and sedation prior to anesthesia, induction and maintenance of anesthesia, and emergence and recovery from anesthesia. The anesthetic protocol will be standardized and the anesthetic management will not deviate from routine practice. The adjuvant therapies for infection prophylaxis and pain control will be administered in the usual fashion.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date May 2008
Est. primary completion date May 2008
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 65 Years
Eligibility Inclusion Criteria:

- mentally retarded persons ages 12 to 65 undergoing dental rehabilitation

Exclusion Criteria:

- patients who are pregnant parents/and or legal guardians who do not wish to give consent

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
BIS monitor
BIS monitor measures the depth of anesthesia and was used in the entire group

Locations

Country Name City State
United States UMDNJ University Hospital Newark New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Rutgers, The State University of New Jersey

Country where clinical trial is conducted

United States, 

References & Publications (1)

Dahaba AA. Different conditions that could result in the bispectral index indicating an incorrect hypnotic state. Anesth Analg. 2005 Sep;101(3):765-73. Review. — View Citation

See also
  Status Clinical Trial Phase
Completed NCT02791321 - Fragility Assessment in Adults With ADHD and Mental Retardation N/A
Recruiting NCT01908400 - Safety and Efficacy of BMMNCin Patients With Mental Retardation Phase 1/Phase 2
Withdrawn NCT02245724 - Stem Cell Therapy in Mental Retardation Phase 1
Completed NCT00156221 - MR Scanning of Very Young Children With Severe Developmental Disorders N/A
Recruiting NCT00491478 - Repetitive Behavior Disorders in People With Severe Mental Retardation Phase 3
Terminated NCT02797418 - "Cognitus & Moi": a New Cognitive Remediation Tool N/A
Completed NCT00758108 - Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Completed NCT01430845 - Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
Not yet recruiting NCT02214745 - Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community N/A
Active, not recruiting NCT00552526 - Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy Phase 4
Completed NCT02943304 - Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
Completed NCT00491894 - Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions Phase 3
Completed NCT01291238 - School Intervention With Daily Physical Activity and Healthy Food for Students With an Intellectual Disability. N/A
Completed NCT01456910 - Resistance Training Program, Labor Inclusion, Intellectual Disability N/A
Completed NCT00065273 - Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay Phase 3
Active, not recruiting NCT00065936 - Self-Injury: Diagnosis and Treatment Phase 3
Completed NCT00506259 - Treatment Strategies for Children With Smith-Magenis Syndrome Phase 1
Not yet recruiting NCT05442229 - A Cross-sectional Study to Evaluate Speech and Language Development in Chinese Children Aged 2-6 Years
Active, not recruiting NCT06370793 - Ningbo Severe Mental Disorders Cohort
Completed NCT01517048 - Brain-Derived Neurotrophic Factor in Obesity and Brain Function